Codman Neurovascular has announced the launch of the Deltamaxx Microcoil System, and Orbit Galaxy G2 Microcoils, which for the first time puts Orbit Galaxy coils on the EnpowerDetachment System, developed by Micrus Endovascular. Both new microcoil systems are now available in the United States and Europe.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker for its Trevo Pro Retriever, a clot removal technology designed to treat patients experiencing acute ischaemic stroke.
Interim results from the START trial, presented at Society of NeuroInterventional Surgery (SNIS, San Diego, USA) 9th Annual Meeting, show advancement in predicting which patients suffering from ischaemic stroke will benefit from endovascular therapy.
Interim results from the START trial, presented at Society of NeuroInterventional Surgery (SNIS, San Diego, USA) 9th Annual Meeting, show advancement in predicting which patients suffering from ischaemic stroke will benefit from endovascular therapy.
The US Food and Drug Administration (FDA) has announced changes to the labeling, including to the indications for use of the Wingspan stent (Boston Scientific/Stryker), which limit its use to a narrow, select group of patients diagnosed with intracranial stenosis.
On 8 August, UK s National Institute of Health and Clinical Excellence (NICE) released a guideline to encourage detailed assessments to people who have neurological conditions like stroke, multiple sclerosis and head and spinal cord injuries, and who experience incontinence or other urinary problems.
A new US study looking at the safety and effectiveness of new medication developed from adult stem cells for the treatment of ischaemic stroke has opened at University Hospitals (UH) Case Medical Center, Cleveland, USA. The phase 2 study will use a cell therapy product called MultiStem (Athersys).
MicroVention, a wholly owned subsidiary of Terumo, has announced initiation of patient enrolment in its HEAT (Hydrogel endovascular aneurysm treatment) clinical trial.
Endovascular therapy (EVT) is associated with significantly better treatment outcomes over traditional intravenous tPA (IVT) for patients suffering acute ischaemic stroke resulting from blockages in the large vessels of the brain, according to a study presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting (San Diego, USA, 23–27 July).
A new study of optical coherence tomography (OCT) confirms the safety and feasibility of this imaging technique in the carotid arteries. However, because of cost issues, OCT still has a long road to travel to become widely utilized, according to a study recently published in the current issue of the Journal of Endovascular Therapy.
A correlation between brain aneurysms, bulges or balloons in vessel walls, and early onset menopause has been identified, according to recent study results presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting (San Diego, USA, 23–27 July) thereby suggesting that the premature loss of estrogen could be a risk factor for aneurysm formation and development.
Blockade Medical has received CE mark for its Barricade Coil System which is designed to occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Preliminary data regarding the use of the Web Aneurysm Embolization System (Sequent Medical) were shared at LINNC 2012 in Paris, France, and published in a recent study in the American Journal of Neuroradiology. The early evidence suggests that this device represents a feasible and promising treatment for wide-neck bifurcation aneurysms, and that further study and clinical experience is warranted.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischaemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study published by Gregg C Fonarow, University of California, Los Angeles, USA, and colleagues.
Lazarus Effect has received CE mark for its Lazarus Funnel Guide Catheter. The device is a single-lumen catheter designed to enhance the introduction and removal of interventional devices, including those used to treat acute ischaemic stroke.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos